Early HPV Vaccine Start Improves Completion Rates
A clinical trial finds that initiating the HPV vaccine at age 9 or 10 boosts vaccination completion among children.
Updated on Oct. 21, 2026 in Cancer
Live Poll
Do you support recommending that children receive their first HPV vaccine dose at age nine?
A multi-year clinical trial conducted between 2021 and 2026 shows that starting the HPV vaccine series at age 9 or 10 leads to higher completion rates compared to beginning at age 11 or 12. Researchers presented the findings in October 2026.
Why it matters
Beginning the vaccine series earlier helps avoid the crowded schedule of shots typically administered at age 11 or 12. It also allows clinicians to frame the HPV vaccine primarily as cancer prevention rather than a sexual health intervention.
The study tracked 62,271 children across 31 pediatric practices in California and Colorado, reporting a 61.6% completion rate for those starting at age 9 or 10 compared to 45.1% for those starting later.
The details
Practices were randomized to either initiate the HPV series at age 9 or 10 or maintain the standard start age of 11 or 12. Participating clinics received training on vaccination recommendations and practice-level data reviews, with results showing no negative impact on the rates of other required vaccines or well-child visits.
Timeline
2021-2026: Clinical trial duration
October 2026: Study results presented at IDWeek
Health Landscape
This study extends the body of evidence regarding pediatric immunization strategies presented at the IDWeek conference. The findings suggest a shift in clinical practice toward earlier intervention to improve long-term preventative health outcomes.
Parents may see pediatricians increasingly recommend the HPV vaccine series beginning at age 9 during routine wellness visits. This earlier start aims to simplify the immunization schedule and ensure children complete the necessary doses for protection.
The takeaway
Starting the HPV vaccine at age 9 or 10 can significantly improve the likelihood of a child receiving all recommended doses. Parents are encouraged to discuss the timing of the vaccine series with their child's healthcare provider to prioritize preventative cancer health.
Further reading
For more context on preventative measures, visit the Cancer section.
Live Poll
Do you support recommending that children receive their first HPV vaccine dose at age nine?
